Women's Cancers Program Executive Council
Research Updates
J. Dirk Iglehart, MD, director of the Women's Cancers Program at Dana-Farber Cancer Institute
Tailored Therapies
In 2004, the WCP Executive Council at Dana-Farber launched the ambitious Tailored Therapies Research Program for Breast Cancer, to promote projects that seek to improve the treatment of women with breast cancer. The program is dedicated to funding investigations of potential genetic and molecular targets and to provide evidence that inhibition of these targets will be therapeutic.
Genetic Fingerprinting
In April 2007, the WCP Executive Council announced a $5 million fundraising goal in support of the WCP Executive Council Genetic Fingerprinting Research Fund for Breast and Ovarian Cancers. Early fundraising success allowed the Women's Cancers Program to put this fund to immediate use and announce a Harvard-wide Research Funding Announcement (RFA) in the summer of 2007. A selection committee was convened and voted to approve four projects, providing a total initial commitment of $250,000 in funds. Projects 1 and 2 were funded for two years, and projects 3 and 4 were partially funded for one year.
